Clinical Trial Update: Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating sacubitril/alisartan for hypertension in overweight or obese patients; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Sacubitril/alisartan (sacubitril/alisartan)

Snippet

Sponsor: Jing Liu | Conditions: Hypertension | Phase 4 | Status: NOT_YET_RECRUITING